Conatus Pharmaceuticals Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Conatus Pharmaceuticals is a biotechnology company based in San Diego, California, focused on developing and commercializing medicines to treat liver disease. Its lead candidate, emricasan, is an oral pan-caspase protease inhibitor described as first-in-class and intended to reduce caspase activity related to inflammation and apoptosis in liver disease. Emricasan has been studied in more than 650 subjects across sixteen clinical trials, with biomarker data suggesting reductions in inflammation and apoptosis across multiple liver disease etiologies and stages. The company has pursued notable collaborations, including a 2016 exclusive option and license agreement with Novartis for global development and commercialization of emricasan, a 2018 expansion of the Novartis collaboration, and a 2020 definitive agreement with Histogen regarding a merger with a Conatus subsidiary. The organization reports revenue in the low millions and employs 11-50 personnel; its website is conatuspharma.com.